Trisalus: Improved Tumor Delivery with PEDD™ Method
TriSalus Life Sciences‘ Pressure Enabled Drug Delivery (PEDD) method enhances the delivery of glass microspheres into liver tumors in...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trial Quality Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
TriSalus Life Sciences‘ Pressure Enabled Drug Delivery (PEDD) method enhances the delivery of glass microspheres into liver tumors in...
LEO Pharma has announced the acceptance of its New Drug Application (NDA) by the U.S. Food and Drug Administration...
A positive efficacy, safety, and tolerability profile has emerged from Medincell and Teva’s Phase 3 SOLARIS trial evaluating Olanzapine...
Ultherapy PRIME, a groundbreaking ultrasound technology, significantly advances noninvasive skin treatments. With real-time imaging, it delivers personalized and long-lasting...
The Virtual Clinical Trials (VCT) market has surged to an estimated USD 2.64 billion in 2023, projected to reach...
This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials...
Today, we had the privilege of sitting with Mumbi Kairu from The Pamoja Research Institute in Anaheim, California. Mumbi...
This is an AI-Generated podcast. The pharmaceutical industry, often viewed as a pillar of global innovation, is facing a...
AngioDynamics has initiated a comprehensive study to evaluate the efficacy and safety of the AlphaVac Mechanical Aspiration Thrombectomy System...
Takeda will showcase data from its Phase 2b trials and long-term extension study of TAK-861, an investigational orexin receptor...